Buy & Sell Uber Technologies Inc (UBER) – Uber Technologies Inc Price Today
Aura AI Summary
Key Stats
- $146.20BMarket Cap
- IndustrialsSector
- -11.07%3M Drawdown
- $152.52BEnterprise Value
- -Dividend Yield
- 62% Buy | 38% SellTrading Activity
- 86 daysTypical Hold Time
Uber Technologies Inc (UBER) is currently valued at a market capitalization of $146.20B, with an enterprise value of $152.52B. Over the past 52 weeks, Uber Technologies Inc has traded between a low of $69.18 and a high of $100.1, highlighting its annual price range. Over the past three months, Uber Technologies Inc has recorded a drawdown of -11.07%, reflecting recent price volatility. On average, investors hold Uber Technologies Inc for approximately 86 days, indicating typical investor behavior on the platform.
About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Most Recent News
Enhanced Games debuts in Las Vegas with boosted athletes and a TikTok-friendly sports format
Enhanced Games will hold its first competition in Las Vegas featuring 50 enhanced athletes, including Olympic and world champions, competing in a new sports format designed for digital and social media viewing. The event combines track, pool, and wei...

Phibro Animal Health CEO sold 21,120 shares worth $1.2 million
Phibro Animal Health's CEO recently sold 21,120 shares of the company, generating proceeds of approximately $1.2 million. This insider sale might indicate the CEO's personal financial planning or a strategic move, but it could also raise questions am...

Patient Square buys 210,000 shares of Nektar Pharmaceuticals, signaling strong confidence.
Patient Square has purchased 210,000 shares of Nektar Pharmaceuticals (NKTR), indicating a significant investment move. This purchase reflects Patient Square's confidence in Nektar's future prospects and potential growth. Investors may view this as a...
